Table 3.

Characteristics of the 13 BP patients whose serum samples were collected in both the disease active and control stages.

	BP patients (n = 13)
Age (years) median (IQR)	57 (51-71.5)
Sex (female/male)	7/6
Female age (years) median (IQR)	56 (46-62)
Male age (years) median (IQR)	71.5 (51.5-79.25)
Disease duration (months) median (IQR)	2 (1-3.5)
Previous history, n (%)	5 (38.5)
Hypertension, n (%)	4 (30.8)
Cerebrovascular disease, n (%)	2 (15.4)
miR-1291 (2-ΔCt), median (IQR), n = 13
Baseline	0.74 (0.28-2.66)
Disease control stage	0.19 (0.08-0.50)
CCL17 (pg/mL) median (IQR), n = 13
Baseline	1557 (387-5906)
Disease control stage	246.3 (86.4-514.2)
Anti‐BP180 > 9 U/mL, median (IQR), n = 10
Baseline	103.5 (66.08-168.2)
Disease control stage	18.09 (4.80-48.58)
Anti‐BP230 > 9 U/mL, median (IQR), n = 9
Baseline	80.87 (27.32-102.9)
Disease control stage	21.61 (2.65-59.63)